%D9%88%D8%B1%D9%85_%D8%A3%D8%B1%D9%88%D9%85%D9%8A_%D9%83%D8%A8%D8%AF%D9%8ACategory:HepatoblastomaHepatoblastomHepatoblastomaHepatoblastoomaH%C3%A9patoblastomeHepatoblastomaEpatoblastoma%E8%82%9D%E8%8A%BD%E8%85%AB%E1%83%B0%E1%83%94%E1%83%9E%E1%83%90%E1%83%A2%E1%83%9D%E1%83%91%E1%83%9A%E1%83%90%E1%83%A1%E1%83%A2%E1%83%9D%E1%83%9B%E1%83%90W%C4%85trobiak_zarodkowyHepatoblastoma%D0%93%D0%B5%D0%BF%D0%B0%D1%82%D0%BE%D0%B1%D0%BB%D0%B0%D1%81%D1%82%D0%BE%D0%BC%D0%B0HepatoblastomaU_nguy%C3%AAn_b%C3%A0o_ganQ1607658
about
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsAuto Transplant for High Risk or Relapsed Solid or CNS TumorsDiagnostic Accuracy of PIVKA-II Combining With Alpha-Fetoprotein in Hepatic TumorCisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After SurgeryBiomarkers in Tissue Samples From Young Patients With Liver CancerAflac ST0901 CHOANOME - Sirolimus in Solid TumorsVemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare TumorsUlixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)the Efficacy and Safety of Sugammadex in Children 0-2 Years OldOlaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver CancerPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Molecular Basis of Pediatric Liver CancerImetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid TumorsSimvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS TumorsAlisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or LeukemiaCollecting and Storing Tissue From Young Patients With CancerSodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other MalignancyCisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver CancerA Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MBCixutumumab in Treating Patients With Relapsed or Refractory Solid TumorsIrinotecan in Treating Young Patients With Refractory or Recurrent HepatoblastomaHepatoblastoma Biology Study and Tissue BankTandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid TumorsOxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentIntensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk HepatoblastomaCombination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver CancerChemotherapy in Treating Children With Liver CancerPaediatric Hepatic International Tumour TrialG-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant TumorCombined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute ExperienceA Compassionate Use Program to Provide Access to Sodium ThiosulfateT Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
P1050
P2175
C3A clone 2.5B1CellSensor ARE-bla Hep G2H7D7AH7D7BH7D7BD5H7D7CH7D7DHB611HC-04HEP G2insHEP G2ins/gHep-G2 A-1Hep-G2 B-1Hep-G2 C-1Hep-G2 SimpleCell O-GalNAcHep-G2 SimpleCell O-GalNAc KI GalNAc-T3Hep-G2 SimpleCell O-GalNAc KO GalNAc-T1Hep-G2 SimpleCell O-GalNAc KO GalNAc-T2Hep-G2/2.2.1Hep-G2/2.2.15Hep-G2/BGALHep-G2/C3AHep-G2/PGC-1alpha 2x9 mutantHep-G2/PGC-1alpha L2L3 mutantHep-G2/PGC-1alpha wtHep-G2/SFHep293TTHepAD38HepAD43HepAD79HepBHAe82HepDE19HepDES19HepG2 CYP3A4G/7R clone 87HepG2 hALRHepG2 Tet-Off AdvancedHepG2 Tet-OnHepG2 Tet-On AdvancedHepG2-DM2HepG2-GS
P5166
Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastomaThe role of BH3-mimetic drugs in the treatment of pediatric hepatoblastomaHepatoblastoma in an 11-year-old: Case report and a review of the literatureMixed hepatoblastoma in an adult--a case report and literature review.Is there a role for high dose chemotherapy and blood stem cell rescue in childhood hepatoblastoma presenting with lung metastases? A case report and literature review.Hepatoblastoma with pure fetal epithelial differentiation in a 10-year-old boy: A rare case report and review of the literature.Metformin attenuates hypoxia-induced resistance to cisplatin in the HepG2 cell lineHepatoblastoma-The Evolution of Biology, Surgery, and TransplantationLongitudinal Monitoring of Alpha-Fetoprotein by Dried Blood Spot for Hepatoblastoma Screening in Beckwith⁻Wiedemann Syndromeand polymorphisms are not associated with hepatoblastoma susceptibility in Chinese childrenThe Role of MicroRNAs in Hepatoblastoma TumorsRobot-assisted gallbladder-preserving hepatectomy for treating S5 hepatoblastoma in a child: A case report and review of the literatureGenetic Profile and Clinical Implications of Hepatoblastoma and Neuroblastoma Coexistence in a ChildCircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and GlutaminolysisPeriostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastomaYttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver TumorsFlavored, Oral Irinotecan (VAL-413) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
P921
Q61904671-5FC3068C-0307-4C17-A922-757CCB668E1CQ61957088-26A670FF-0220-42CC-99D5-957A7E29306FQ62025810-D23816F7-1A60-485E-8726-772CC1DBE8E9Q62815257-40D40EDC-D88F-4BFF-B13F-9AA1D6F42982Q63335772-79D51409-8E7B-4BC0-AD9A-D9078862001CQ63337746-1C1F5765-0F17-4C81-9D0F-231428C92CCFQ63573040-3A2E76B1-4E8D-4272-8D06-8856CC6F6F66Q63573228-CF48DA3D-5EB4-48A8-BB2B-54807FDB73DCQ63574661-78ACA01F-D44B-4BD7-8E6A-D421EB70C646Q63587860-12C73B0E-831A-4AE4-8D47-E05BC28B00B3Q63596661-00C52010-9ADD-4114-8082-98C882206312Q63807711-7D438D89-B551-45A5-8876-F24F950754E2Q63807717-EEFCE08B-3D85-47DF-8BF8-B5BDD4AA5A57Q63807719-012DB8E2-CBA3-4EE4-81FD-18CA9E422E9CQ63807720-8CDB8A03-4EF5-4BC6-8C05-6E594970B2BEQ63807725-200847C4-7168-4F61-B967-80DC87331741Q63808061-8CE5F862-85EE-4391-A96D-EA0850BDB2E5Q64150599-DB2B2B2D-C359-4F9A-93FB-02B92C379673Q64151141-73E00DB7-A602-4E19-BE06-0F8BA09E75A1Q64351095-DD814CB2-76B7-442E-B412-9FBAB616A1A3Q64397307-0B199D07-F49E-45A6-BC6B-A6AC846FA20FQ64654884-1C49FE8E-72DA-4778-AB33-64B15D597E8CQ64676309-263C414A-964A-4410-BC37-E1D456DD31C0Q64718396-B203D95E-DD1C-4367-9656-2D823B76BBD5Q64720367-8B1D0B70-D9B7-41E6-8733-555598F9D27CQ65376296-4E86287E-49D7-4361-8B02-8E30891C23DCQ65377317-01494497-5FCC-4F67-A994-EF5A55169D1CQ65537381-849131A6-9145-4E70-BDE0-3639A666EE8CQ65542816-BA764EE3-6B4D-4BDD-9309-CC051DDCC988Q66026028-F09C2C53-DD5E-4B7A-8DD7-05748F59C0D3Q66032626-C9A91A02-34F6-4972-AA01-3574A049D7EDQ66035214-F6CA2BA1-724E-446F-B3DD-FF9D74B7C86AQ66037914-AC5235DC-1CCE-483D-801C-15AB5969FEE4Q66037934-84ADEE5B-D3D4-4393-AC99-ADFE4A0680FFQ66075525-8F892106-11C8-4D7F-98E5-0500B49F99E4Q66080588-A6B2CE4B-676A-4C27-B792-84583755F905Q67126751-03264B48-E37B-4E4F-A18A-5BB91838635AQ74274711-B0A7209E-01FA-445D-A263-FB21854C0784Q74280556-67F5B4A4-E2AF-4DBF-8415-6D120CC49599Q79111505-EFB80C25-78A3-478A-8211-A0F3FACB076C
P1050
Q54808152-70E92D82-4FBE-4BDA-8598-01D72F70DF03Q54809167-6E274484-F640-4F07-9EAC-022ED87721A7Q54872220-A5762930-6AF0-423A-8C4C-7C0DF2569F30Q54872221-5C86DE63-8B6F-4A58-9796-82CB68B93699Q54872222-83FBC676-A11E-46A0-8F5F-91B835AA8A8FQ54872223-79B6052B-C40B-46CE-81F4-D4D324D98442Q54872224-A84A8689-846E-41B1-B8CE-23C745411BD8Q54881366-4555FAC1-43B6-41FA-BB90-8775CAB644A4Q54881462-32E59452-8CD4-4AA2-804E-9345EFC5B4FEQ54882748-69632FF6-9FCB-44FC-A071-93898C715D35Q54882749-8155F48E-5B92-43B9-9A1A-337B7619DF11Q54882779-D9931ECD-AB3C-4432-9DE2-D64EF7792086Q54882780-698F07CD-75D4-40DD-9E61-FF131093F252Q54882781-47E48BF8-9CCF-447B-BDB7-5BB0F819453FQ54882782-3A8EF027-EE68-4D4C-AF55-112C8C4E3BA8Q54882783-64E254DF-941A-492D-809F-109DA9DCB7D7Q54882784-36BF8BFF-86AA-42AF-A9DD-B304A724DE76Q54882785-35EA1ACA-15CB-41FC-BBBD-FB2815C744E2Q54882786-E3F4B43F-2872-4F3B-B457-B9C959C3AC0FQ54882787-4850877A-46C8-436D-9820-87A9D693856EQ54882788-2221ADF3-C692-47B7-B514-C722D9FABF61Q54882789-63C5F55B-A703-409B-89DF-59EF0FD39F44Q54882790-34EE34D6-A347-40CC-ADF2-45FD80369B4DQ54882791-A1997DA2-85C9-4FF3-A758-B59C2B7D3B80Q54882792-26CD5AA1-CC0A-40BF-9A12-EAA563EE4F69Q54882793-F739850A-1AE9-455A-AC0B-2CDF7F20EB44Q54882806-945B601C-69E8-47B7-BCCD-89274A728FC1Q54882829-E5B8BBC4-8445-4576-867C-9D8E5655DDF7Q54882830-7956EFEF-839B-42D8-AEBD-7CC84FF46F3EQ54882831-3BD99BC7-053E-46A4-822D-BD908BFAD5D5Q54882837-B5D0F47E-BB7D-4119-A6FB-C8D8E10ABE76Q54882838-6DE0C60A-ADE8-40CA-B13C-5A3E48C5C0F9Q54882839-846C8B75-4EE2-44CD-A418-23EA7233F55FQ54882844-04CA6DE8-AFD4-4598-838F-D3CF53A96979Q54882845-4750214A-513B-4455-827A-14BC9EC0758DQ54882846-DB541E0E-95B1-4966-BD24-D165363AECCBQ54882847-0136F4BD-15E7-4C48-A0C7-2F86E38DB705Q54882848-D177CCEA-F4F8-45B2-B18B-05696885C93AQ54882849-31DB8FC0-649C-43AF-84C0-CF01D2B42270Q54882850-2AB4D4F9-7EA4-4B3D-BC9A-40933E438431
P5166
description
Krankheit
@de
tumeur maligne rare du foie, d ...... es nourrissons et les enfants.
@fr
tumore epatico più frequente dell'età infantile
@it
uncommon malignant liver cancer occurring in infants and children
@en
مرض يصيب الإنسان
@ar
name
Hepatoblastom
@de
Hepatoblastoma
@id
Hepatoblastoma
@pl
Hepatoblastooma
@fi
U nguyên bào gan
@vi
epatoblastoma
@it
hepatoblastoma
@en
hepatoblastoma
@es
hepatoblastoma
@nl
hepatoblastoma
@pt
type
label
Hepatoblastom
@de
Hepatoblastoma
@id
Hepatoblastoma
@pl
Hepatoblastooma
@fi
U nguyên bào gan
@vi
epatoblastoma
@it
hepatoblastoma
@en
hepatoblastoma
@es
hepatoblastoma
@nl
hepatoblastoma
@pt
altLabel
HBL
@en
HEPATOBLASTOMA, MALIGNANT
@en
Hepatoblastoma
@en
Pediatric Embryonal Hepatoma
@en
Pediatric Hepatoblastoma
@en
blastoma del higado
@es
blastoma del hígado
@es
blastoma hepatico
@es
blastoma hepático
@es
prefLabel
Hepatoblastom
@de
Hepatoblastoma
@id
Hepatoblastoma
@pl
Hepatoblastooma
@fi
U nguyên bào gan
@vi
epatoblastoma
@it
hepatoblastoma
@en
hepatoblastoma
@es
hepatoblastoma
@nl
hepatoblastoma
@pt
P2888
P486
P5806
P6366
P646
P672
P1748
P1995
P2176
P279
P2892
P31
P373
Hepatoblastoma
P3827
hepatoblastoma
P3841
HP:0002884